AbCellera Biologics (8QQ) Cash flow

Compare

2 Followers

AbCellera Biologics Cash Flow

DE:8QQ's free cash flow for Q4 2025 was $-44.59M. For the 2025 fiscal year, DE:8QQ's free cash flow was decreased by $12.88M and operating cash flow was $-34.74M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -131.29M	$ -108.56M	$ -43.88M	$ 277.36M	$ 244.58M
Investing Cash Flow	$ 87.75M	$ 121.41M	$ -221.11M	$ -352.63M	$ -332.25M
Financing Cash Flow	$ 14.08M	$ 12.77M	$ 10.36M	$ -1.63M	$ -3.89M
End Cash Position	$ 155.25M	$ 183.62M	$ 160.61M	$ 414.65M	$ 501.14M
Free Cash Flow	$ -174.07M	$ -186.95M	$ -121.38M	$ 204.70M	$ 186.13M

Currency in USD